XML 50 R35.htm IDEA: XBRL DOCUMENT v3.22.2
Revenue Recognition (Tables)
 6 Months Ended
Jun. 30, 2022
Revenue from Contract with Customer [Abstract]  
Disaggregation of revenue
The following table represents Evolent’s revenue disaggregated by segment and end-market for (in thousands):
For the Three Months Ended June 30,For the Six Months Ended June 30,
20222021202220212022202120222021
Evolent Health ServicesClinical SolutionsEvolent Health ServicesClinical Solutions
Medicaid$55,422 $52,064 $86,080 $53,648 $122,336 $112,993 $156,967 $96,987 
Medicare9,863 6,346 101,529 90,761 14,696 14,684 193,796 176,544 
Commercial and other27,051 16,453 39,994 2,785 62,162 32,023 67,039 3,897 
Total$92,336 $74,863 $227,603 $147,194 $199,194 $159,700 $417,802 $277,428 
Contract with customer, asset and liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of June 30, 2022 and December 31, 2021 (in thousands):
June 30, 2022December 31, 2021
Short-term receivables (1)
$116,580 $129,012 
Long-term receivables (1)
5,038 4,877 
Short-term deferred revenue8,711 11,944 
Long-term deferred revenue3,605 4,437 
————————
(1)Excludes pharmacy claims receivable and premiums receivable.

Changes in deferred revenue for the six months ended June 30, 2022 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$16,381 
Reclassification to revenue, as a result of performance obligations satisfied(10,796)
Cash received in advance of satisfaction of performance obligations6,731 
Balance as of end of period$12,316